These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20439526)

  • 1. Tocilizumab for rheumatoid arthritis with chronic hepatitis B virus infection without antiviral therapy.
    Nagashima T; Minota S
    J Rheumatol; 2010 May; 37(5):1066; author reply 1067. PubMed ID: 20439526
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term tocilizumab therapy in a patient with rheumatoid arthritis and chronic hepatitis B.
    Nagashima T; Minota S
    Rheumatology (Oxford); 2008 Dec; 47(12):1838-40. PubMed ID: 18854348
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of infliximab in a patient with rheumatoid arthritis and chronic hepatitis B.
    Doubrawa E; Ricca RA; Malucelli TO; Pizzol VI; Barros DH; Paiva ES
    Rev Bras Reumatol; 2012 Aug; 52(4):653-5. PubMed ID: 22885430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-TNF-alpha therapy for rheumatoid arthritis among patients with chronic hepatitis B infection.
    Robinson H; Walker-Bone K
    Rheumatology (Oxford); 2009 Apr; 48(4):448-50. PubMed ID: 19223285
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of anti-TNF-alpha therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis.
    Roux CH; Brocq O; Breuil V; Albert C; Euller-Ziegler L
    Rheumatology (Oxford); 2006 Oct; 45(10):1294-7. PubMed ID: 16603583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tocilizumab for rheumatoid arthritis.
    Drug Ther Bull; 2010 Jan; 48(1):9-12. PubMed ID: 20040568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful use of adalimumab for treating rheumatoid arthritis with autoimmune sensorineural hearing loss: two birds with one stone.
    Morovic Vergles J; Radic M; Kovacic J; Salamon L
    J Rheumatol; 2010 May; 37(5):1080-1. PubMed ID: 20439536
    [No Abstract]   [Full Text] [Related]  

  • 9. Tocilizumab and missed personalized medicine opportunities for patients with rheumatoid arthritis?
    Littman BH
    Arthritis Rheum; 2009 May; 60(5):1565-6. PubMed ID: 19404928
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidence.
    Siddiqui MA
    Curr Opin Rheumatol; 2007 May; 19(3):308-13. PubMed ID: 17414961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy.
    Nagashima T; Minota S
    J Rheumatol; 2011 Mar; 38(3):574; author reply 575. PubMed ID: 21362792
    [No Abstract]   [Full Text] [Related]  

  • 12. Tocilizumab (Actemra) for rheumatoid arthritis.
    Med Lett Drugs Ther; 2010 Jun; 52(1340):47-8. PubMed ID: 20539266
    [No Abstract]   [Full Text] [Related]  

  • 13. Ophthalmic herpes zoster infection in patients with rheumatoid arthritis who were treated with tocilizumab.
    Roux C; Breuil V; Albert C; Allam V; Grisot C; Chami H; Dasilva V; Euller-Ziegler L
    J Rheumatol; 2011 Feb; 38(2):399. PubMed ID: 21285184
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of refractory rheumatoid arthritis-associated leg ulcerations with adalimumab.
    Hirche D; Rubbert A; Lunau L; Krieg T; Eming SA
    Br J Dermatol; 2005 May; 152(5):1062-4. PubMed ID: 15888173
    [No Abstract]   [Full Text] [Related]  

  • 15. Tocilizumab: new drug. Rheumatoid arthritis: another 'mab', no therapeutic advantage.
    Prescrire Int; 2009 Oct; 18(103):198-201. PubMed ID: 19882783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of rheumatic diseases and hepatitis B virus coinfection.
    Felis-Giemza A; Olesińska M; Świerkocka K; Więsik-Szewczyk E; Haładyj E
    Rheumatol Int; 2015 Mar; 35(3):385-92. PubMed ID: 25549599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.
    Genovese MC; McKay JD; Nasonov EL; Mysler EF; da Silva NA; Alecock E; Woodworth T; Gomez-Reino JJ
    Arthritis Rheum; 2008 Oct; 58(10):2968-80. PubMed ID: 18821691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of C-reactive protein levels and febrile tendency after joint surgery in rheumatoid arthritis patients treated with a perioperative 4-week interruption of tocilizumab.
    Hiroshima R; Kawakami K; Iwamoto T; Tokita A; Yano K; Sakuma Y; Ikari K; Momohara S
    Mod Rheumatol; 2011 Feb; 21(1):109-11. PubMed ID: 20824299
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection.
    Vassilopoulos D; Apostolopoulou A; Hadziyannis E; Papatheodoridis GV; Manolakopoulos S; Koskinas J; Manesis EK; Archimandritis AI
    Ann Rheum Dis; 2010 Jul; 69(7):1352-5. PubMed ID: 20472596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocilizumab versus adalimumab for rheumatoid arthritis.
    Felson DT
    Lancet; 2013 Aug; 382(9890):394-395. PubMed ID: 23911375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.